Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cell migration plays a critical role during the development of most organisms and the process of malignant tumor metastasis. In the present study, we investigated the role of
PTPIP51
(protein tyrosine phosphatase interacting protein 51) in cell motility. Overexpression of
PTPIP51
induced cell elongation, increased cell migration, adhesion, and spreading, while downregulation of
PTPIP51
had the opposite effects. We demonstrated here, that
PTPIP51
could regulate ERK activity on Raf level, since
MEK
inhibitor and dominant-negative Raf-1 but not Ras could inhibit the ERK activation induced by
PTPIP51
. Further studies proved that
PTPIP51
could interact with Raf-1 through 14-3-3, suggesting that
PTPIP51
is a regulator of the Raf-
MEK
-ERK cascade through modulation of Raf-1 by 14-3-3. In addition, two redundant 14-3-3 binding domains in the
PTPIP51
protein have been identified by deletion/mutation studies. We conclude that
PTPIP51
regulates cell morphology and cell motility via interaction with Raf-1 through 14-3-3, and that
PTPIP51
binds to 14-3-3 through two redundant binding domains.
...
PMID:PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway. 1877 26